222 related articles for article (PubMed ID: 16159444)
1. [A method of showing thermal effect of iron oxide nanoparticles in alternating magnetic field].
Liu X; Xu B; Xia QS; Zhao TD; Tang JT
Ai Zheng; 2005 Sep; 24(9):1148-50. PubMed ID: 16159444
[TBL] [Abstract][Full Text] [Related]
2. Heat-Generating Iron Oxide Multigranule Nanoclusters for Enhancing Hyperthermic Efficacy in Tumor Treatment.
Jeon S; Park BC; Lim S; Yoon HY; Jeon YS; Kim BS; Kim YK; Kim K
ACS Appl Mater Interfaces; 2020 Jul; 12(30):33483-33491. PubMed ID: 32614594
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of PEG-iron oxide core-shell composite nanoparticles for thermal therapy.
Wydra RJ; Kruse AM; Bae Y; Anderson KW; Hilt JZ
Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4660-6. PubMed ID: 24094173
[TBL] [Abstract][Full Text] [Related]
4. Effect of heat dissipation of superparamagnetic nanoparticles in alternating magnetic field on three human cancer cell lines in magnetic fluid hyperthermia.
Attar MM; Haghpanahi M
Electromagn Biol Med; 2016; 35(4):305-20. PubMed ID: 27015154
[TBL] [Abstract][Full Text] [Related]
5. Optimization Study on Specific Loss Power in Superparamagnetic Hyperthermia with Magnetite Nanoparticles for High Efficiency in Alternative Cancer Therapy.
Caizer C
Nanomaterials (Basel); 2020 Dec; 11(1):. PubMed ID: 33375292
[TBL] [Abstract][Full Text] [Related]
6. A multi-controlled drug delivery system based on magnetic mesoporous Fe
Zhang Q; Liu J; Yuan K; Zhang Z; Zhang X; Fang X
Nanotechnology; 2017 Oct; 28(40):405101. PubMed ID: 28837053
[TBL] [Abstract][Full Text] [Related]
7. Contribution of a 300 kHz alternating magnetic field on magnetic hyperthermia treatment of HepG2 cells.
Wang X; Chen Y; Huang C; Wang X; Zhao L; Zhang X; Tang J
Bioelectromagnetics; 2013 Feb; 34(2):95-103. PubMed ID: 23059525
[TBL] [Abstract][Full Text] [Related]
8. N-Hydroxysuccinamide functionalized iron oxide nanoparticles conjugated with 5-flurouracil for hyperthermic therapy of malignant liver cancer cells by DNA repair disruption.
Veeramani S; Chandrababu L; Rajangam I; Singh NR; Al-Humaid L; Al-Dahmash ND; Balaji R; Chandrasekar N; Hwang MT
Int J Biol Macromol; 2023 Oct; 250():126001. PubMed ID: 37532190
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific nano-entities for optical detection and hyperthermic treatment of breast cancer.
Jin H; Hong B; Kakar SS; Kang KA
Adv Exp Med Biol; 2008; 614():275-84. PubMed ID: 18290338
[TBL] [Abstract][Full Text] [Related]
10. Application of novel metal nanoparticles as optical/thermal agents in optical mammography and hyperthermic treatment for breast cancer.
Jin H; Kang KA
Adv Exp Med Biol; 2007; 599():45-52. PubMed ID: 17727246
[TBL] [Abstract][Full Text] [Related]
11. Induced heat property of polyethyleneglycol-coated iron oxide nanoparticles with dispersion stability for hyperthermia.
Jang DH; Lee YI; Kim KS; Park ES; Kang SC; Yoon TJ; Choa YH
J Nanosci Nanotechnol; 2013 Sep; 13(9):6098-102. PubMed ID: 24205608
[TBL] [Abstract][Full Text] [Related]
12. High therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor area.
Kossatz S; Ludwig R; Dähring H; Ettelt V; Rimkus G; Marciello M; Salas G; Patel V; Teran FJ; Hilger I
Pharm Res; 2014 Dec; 31(12):3274-88. PubMed ID: 24890197
[TBL] [Abstract][Full Text] [Related]
13. Poly(ethylene glycol)-based magnetic hydrogel nanocomposites for hyperthermia cancer therapy.
Meenach SA; Hilt JZ; Anderson KW
Acta Biomater; 2010 Mar; 6(3):1039-46. PubMed ID: 19840875
[TBL] [Abstract][Full Text] [Related]
14. Thermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility study.
Hilger I; Hiergeist R; Hergt R; Winnefeld K; Schubert H; Kaiser WA
Invest Radiol; 2002 Oct; 37(10):580-6. PubMed ID: 12352168
[TBL] [Abstract][Full Text] [Related]
15. Application of biocompatible and ultrastable superparamagnetic iron(III) oxide nanoparticles doped with magnesium for efficient magnetic fluid hyperthermia in lung cancer cells.
Nowicka AM; Ruzycka-Ayoush M; Kasprzak A; Kowalczyk A; Bamburowicz-Klimkowska M; Sikorska M; Sobczak K; Donten M; Ruszczynska A; Nowakowska J; Grudzinski IP
J Mater Chem B; 2023 May; 11(18):4028-4041. PubMed ID: 36960952
[TBL] [Abstract][Full Text] [Related]
16. Characterization of PEG-iron oxide hydrogel nanocomposites for dual hyperthermia and paclitaxel delivery.
Meenach SA; Shapiro JM; Hilt JZ; Anderson KW
J Biomater Sci Polym Ed; 2013; 24(9):1112-26. PubMed ID: 23683041
[TBL] [Abstract][Full Text] [Related]
17. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer.
Ivkov R; DeNardo SJ; Daum W; Foreman AR; Goldstein RC; Nemkov VS; DeNardo GL
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7093s-7103s. PubMed ID: 16203808
[TBL] [Abstract][Full Text] [Related]
18. Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.
Li FR; Yan WH; Guo YH; Qi H; Zhou HX
Int J Hyperthermia; 2009 Aug; 25(5):383-91. PubMed ID: 19391033
[TBL] [Abstract][Full Text] [Related]
19. Biocompatible Nanoclusters with High Heating Efficiency for Systemically Delivered Magnetic Hyperthermia.
Albarqi HA; Wong LH; Schumann C; Sabei FY; Korzun T; Li X; Hansen MN; Dhagat P; Moses AS; Taratula O; Taratula O
ACS Nano; 2019 Jun; 13(6):6383-6395. PubMed ID: 31082199
[TBL] [Abstract][Full Text] [Related]
20. Using thermal energy produced by irradiation of Mn-Zn ferrite magnetic nanoparticles (MZF-NPs) for heat-inducible gene expression.
Tang QS; Zhang DS; Cong XM; Wan ML; Jin LQ
Biomaterials; 2008 Jun; 29(17):2673-9. PubMed ID: 18396332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
